Mark A. Goldsmith serves as Executive at CONSTELLATION PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Mark A. Goldsmith has executed 153 insider transactions totaling $29.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 5, 2020 involved selling 3,145 shares valued at $125.8K.
Mark A. Goldsmith currently holds 144,493 shares of CONSTELLATION PHARMACEUTICALS INC (CNST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark A. Goldsmith has been a net seller of CNST stock. They have purchased $0 and sold $29.4M worth of shares.
Mark A. Goldsmith's most recent insider trade was on May 5, 2020, when they sold 3,145 shares at $40.01 per share.
Get notified when new Form 4 filings are submitted
| $1.55 |
| Discretionary |
| Apr 27, 2020 | CNST | $16.0K | Sale | 400 | $40.12 | Discretionary |